Skip to Content


Coronavirus vaccine information for the media

PLEASE NOTE! We are receiving a lot of claims and contacts as the coronavirus vaccination programme progresses. We are now focusing on processing injury reports with optimal efficiency. You may accordingly not be able to contact us as quickly as usual. We respond to media inquiries with all possible speed.

The most rapid responses are generally made to questions submitted by e-mail to Please leave requests for telephone contact on +358 10 219 5712 (weekdays from 10 am to 1 pm).

Here is some information about coronavirus and our answers to frequently asked questions. We update this information at about once a month.


1 749 injury reports have been submitted and 1 339 decisions have been issued by the end of April 2022 on coronavirus vaccines, of which 482 have resulted in compensation payments and 857 have declined the claim. While we seek to process cases expeditiously, the principle of diligence is not compromised.

Compensation has so far been paid for temporary inconvenience, medical expenses arising from injury, and loss of earnings in some cases. Adverse reactions have mainly been mild. Expenses are reimbursed according to true documented costs. Compensation for lost earnings is paid according to earnings actually lost.

Compensation has so far been paid mainly for various allergic reactions and pain caused by the vaccine, such as pain in the vaccination arm, and joint and muscle pain. Compensation has also been paid for other reasons in individual cases, but these cannot yet be outlined for reasons of data protection. We shall publish additional information if cases accrue to the extent that the personal privacy of individuals is not compromised by disclosing information. No serious unknown adverse reactions have been described in injury reports to date.



Usein kysyttyjä kysymyksiä vastauksineen

Back to the top